StockNews.com upgraded shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. Amneal Pharmaceuticals Stock Performance Shares of AMRX opened at $1.88 on Tuesday. Amneal Pharmaceuticals has a 12 month low of $1.24 and a 12 month high of $3.77. The company has […]
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) had its target price trimmed by Piper Sandler from $5.00 to $3.00 in a research note published on Monday morning, The Fly reports. Other analysts also recently issued research reports about the stock. StockNews.com initiated coverage on shares of Amneal Pharmaceuticals in a report on Friday, March 17th. They […]
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. Amneal Pharmaceuticals Stock Performance AMRX traded up $0.10 during trading on Monday, hitting $2.02. 751,600 shares of the stock traded hands, compared to its average volume […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target […]